Biomedical Engineering Reference
In-Depth Information
sion in a cohort of ambulatory COPD patients: a multiple logistic regression
analysis. The EOLO Study Group. Respiration 2000; 67:495-501.
50. Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and
death from pulmonary infection. Eur Respir J 1995; 8:1333-1338.
51. Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic
value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med
2002; 166:329-332.
52. Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, Rogers
RM, Hayashi S, Hogg JC. Amplification of inflammation in emphysema and its
association with latent adenoviral infection. Am J Respir Crit Care Med 2001;
164:469-473.
53. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense
mechanism for mammalian airways. J Clin Invest 2002; 109:571-577.
54. Athman R, Philpott D. Innate immunity via Toll-like receptors and Nod
proteins. Curr Opin Microbiol 2004; 7:25-32.
55. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B,
Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000;
18:767-811.
56. Castellano G, Woltman AM, Schena FP, Roos A, Daha MR, Kooten CC.
Dendritic cells and complement: at the cross road of innate and adaptive immu-
nity. Mol Immunol 2004; 41:133-140.
57. Turato G, Di Stefano A, Maestrelli P, Mapp CE, Ruggieri MP, Roggeri A,
Fabbri LM, Saetta M. Effect of smoking cessation on airway inflammation
in chronic bronchitis. Am J Respir Crit Care Med 1995; 152:1262-1267.
58. Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, Van der Mark TW,
Koeter GH, Timens W. Ongoing airway inflammation in patients with COPD
who do not currently smoke. Thorax 2000; 55:12-18.
59. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smok-
ing cessation and lung function in mild-to-moderate chronic obstructive
pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med
2000; 161:381-390.
60. Culpitt SV, Nightingale JA, Barnes PJ. Effect of high dose inhaled steroid on
cells, cytokines and proteases in induced sputum in chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 1999; 160:1635-1639.
61. Russell RE, Thorley A, Culpitt SV, Dodd S, Donnelly LE, Demattos C,
Fitzgerald M, Barnes PJ. Alveolar macrophage-mediated elastolysis: roles of
matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung
Cell Mol Physiol 2002; 283:L867-L873.
62. Culpitt SV, Rogers DF, Shah P, de Matos C, Russell RE, Donnelly LE, Barnes
PJ. Impaired inhibition by dexamethasone of cytokine release by alveolar
macrophages from patients with chronic obstructive pulmonary disease. Am
J Respir Crit Care Med 2003; 167:24-31.
63. Barnes PJ. Molecular genetics of chronic obstructive pulmonary disease.
Thorax 1999; 54:245-252.
64. Lomas DA, Silverman EK. The genetics of chronic obstructive pulmonary
disease. Respir Res 2001; 2:20-26.
